Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT
Summit Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | -235K | n/a | 235K | n/a | 705.00 | 220K | 235K | 250K | 251K | 1.31M | 57K | 192K |
Cost of Revenue | 37K | 25K | 14.94M | 20K | 20K | 27K | 605K | 599K | 471K | n/a | 596K | n/a | 41.95K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -37K | -25K | -14.94M | -20K | -20K | -27K | -840K | -599K | -236K | n/a | -595K | 220K | 193.05K | 250K | 251K | 1.31M | 57K | 192K |
Operating Income | -568.44M | -66.85M | -65.61M | -58.11M | -59.62M | -42.39M | -28.4M | -20.49M | -15.79M | -537.15M | -20.3M | -16.94M | -12.69M | -22.16M | -26.05M | -19.49M | -23.73M | -16.92M |
Interest Income | 2.98M | 3.86M | 13.47M | n/a | n/a | n/a | 2.38M | 2.48M | 3.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -565.71M | -62.91M | -61.18M | -56.25M | -60.38M | -43.47M | -36.57M | -21.27M | -14.72M | -542.38M | -19.23M | -19.15M | -13.78M | -21.4M | -20.04M | -19.6M | -17.65M | -12.69M |
Net Income | -565.71M | -62.91M | -61.2M | -56.25M | -60.38M | -43.47M | -28.68M | -21.27M | -14.72M | -542.38M | -19.23M | -21.39M | -16.77M | -21.4M | -25.73M | -19.6M | -24.42M | -17.49M |
Selling & General & Admin | 360.38M | 15.59M | 14.41M | 20.39M | 13.95M | 11.52M | 11.61M | 5.43M | 6.32M | 6.94M | 7.54M | 5.57M | 6.93M | 6.66M | 7.78M | 5.66M | 5.98M | 4.18M |
Research & Development | 208.02M | 51.27M | 51.4M | 37.72M | 30.8M | 30.87M | 19.46M | 15.32M | 9.45M | 9.88M | 5.39M | 17.05M | 9.01M | 20.56M | 23.11M | 19.94M | 17.3M | 14.7M |
Other Expenses | n/a | n/a | -196K | 264K | 14.85M | n/a | -104K | -64K | 27K | 520.33M | 7.38M | -4.89M | -2.48M | -3.66M | -1.05M | -113K | -686K | -3.95M |
Operating Expenses | 568.4M | 66.85M | 65.61M | 58.38M | 59.62M | 42.39M | 36.24M | 20.76M | 15.79M | 537.15M | 20.3M | 17.16M | 12.93M | 22.41M | 26.3M | 20.8M | 23.79M | 17.11M |
Interest Expense | n/a | n/a | 9K | 2.46M | 3.1M | 3.12M | 2.9M | 2.72M | 2.52M | 8.33M | 2.9M | 692K | 653K | 152K | 1.05M | 113K | 216K | 565K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 568.44M | 66.85M | 65.61M | 58.11M | 59.62M | 42.39M | 36.24M | 16.8M | 15.79M | 537.15M | 16.79M | 17.16M | 12.93M | 22.41M | 26.3M | 20.8M | 23.79M | 17.11M |
Income Tax Expense | n/a | n/a | n/a | 264K | -159K | n/a | 2.79M | -599K | n/a | n/a | -2.9M | 4.45M | 639K | -761K | 1.05M | 113K | 686K | 565K |
Shares Outstanding (Basic) | 742.62M | 738.08M | 737.5M | 703.17M | 670.94M | 701.78M | 701.66M | 697.74M | 697.68M | 378.16M | 211.09M | 148.58M | 99.65M | 98.07M | 96.72M | 97.45M | 90.65M | 82.82M |
Shares Outstanding (Diluted) | 742.62M | 738.08M | 737.5M | 726.66M | 707.9M | 701.78M | 701.66M | 697.74M | 697.68M | 378.16M | 211.09M | 148.58M | 99.65M | 98.07M | 96.78M | 98.97M | 92.07M | 82.82M |
EPS (Basic) | -0.76 | -0.09 | -0.08 | -0.08 | -0.09 | -0.06 | -0.05 | -0.03 | -0.02 | -1.43 | -0.08 | -0.1 | -0.12 | -0.15 | -0.28 | -0.2 | -0.27 | -0.21 |
EPS (Diluted) | -0.76 | -0.09 | -0.08 | -0.08 | -0.09 | -0.06 | -0.05 | -0.03 | -0.02 | -1.43 | -0.08 | -0.1 | -0.12 | -0.15 | -0.28 | -0.2 | -0.27 | -0.21 |
EBITDA | -565.67M | -62.89M | -61.15M | -53.52M | -57.26M | -40.33M | -33.06M | -18.51M | -12.16M | -533.96M | -15.73M | -19.98M | -15.53M | -20.63M | -27.51M | -18.97M | -23.54M | -16.44M |
EBIT | -565.71M | -62.91M | -61.17M | -53.8M | -57.28M | -40.35M | -33.67M | -18.55M | -12.2M | -534.05M | -16.32M | -20.69M | -16.12M | -21.25M | -28.18M | -19.6M | -24.2M | -16.92M |
Depreciation & Amortization | 37K | 25K | -67K | 20K | 20K | 27K | 605K | 32K | 46K | 90K | 596K | 712K | 591K | 615K | 671K | 632K | 665K | 487K |